BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21114195)

  • 1. Vitamin K2: a novel therapy for osteoporosis.
    Prabhoo R; Prabhoo TR
    J Indian Med Assoc; 2010 Apr; 108(4):253-4, 256-8. PubMed ID: 21114195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K2 in bone metabolism and osteoporosis.
    Plaza SM; Lamson DW
    Altern Med Rev; 2005 Mar; 10(1):24-35. PubMed ID: 15771560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitamin K2 treatment for osteoporosis: what is the evidence today?].
    Ishida Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():409-14. PubMed ID: 18161141
    [No Abstract]   [Full Text] [Related]  

  • 5. [A-TOP research group/JOINT program].
    Kuroda T; Miyakawa N; Miyazaki T; Shiraki M
    Nihon Rinsho; 2009 May; 67(5):1017-21. PubMed ID: 19432126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
    Hosoi T;
    Clin Calcium; 2007 Jul; 17(7):1098-104. PubMed ID: 17607078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanana I; Oshima H
    Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.
    Lanham-New SA
    Proc Nutr Soc; 2008 May; 67(2):163-76. PubMed ID: 18412990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitamin K2 (menatetrenone) and bone quality].
    Iinuma N
    Clin Calcium; 2005 Jun; 15(6):1034-9. PubMed ID: 15930719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of primary osteoporosis with vitamin K2].
    Hosoi T
    Clin Calcium; 2007 Nov; 17(11):1727-30. PubMed ID: 17982193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
    Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
    J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone health: the role of micronutrients.
    New SA
    Br Med Bull; 1999; 55(3):619-33. PubMed ID: 10746351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Clin Calcium; 2007 Nov; 17(11):1738-44. PubMed ID: 17982195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of concurrent treatment with vitamin K
    Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M
    J Bone Miner Metab; 2017 Jul; 35(4):385-395. PubMed ID: 27484436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin K2].
    Shiraki M
    Nihon Rinsho; 1998 Jun; 56(6):1525-30. PubMed ID: 9648476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concurrent treatment of osteoporosis including vitamin K].
    Kobayashi S; Shiraki M; Takaoka K
    Clin Calcium; 2007 Nov; 17(11):1731-7. PubMed ID: 17982194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].
    Yamauchi M;
    Clin Calcium; 2007 Jul; 17(7):1106-13. PubMed ID: 17607079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of osteoporosis with vitamin K2].
    Shiraki M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():404-9. PubMed ID: 15035160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.